Schoenberg M
Laboratory of Physical Biology, National Institutes of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland 20892.
Biophys J. 1989 Jul;56(1):33-41. doi: 10.1016/S0006-3495(89)82650-5.
It is commonly believed, for both vertebrate striated and insect flight muscle, that when the ATP analogue adenyl-5'-yl imidodiphosphate (AMPPNP) is added to the muscle fiber in rigor, it causes the fiber to lengthen by 0.15%. This has been interpretated (Marston S.B., C.D. Roger, and R.T. Tregear. 1976. J. Mol. Biol. 104:263-267) as suggesting (a) that in rigor the crossbridge is fixed to, i.e., almost never detaches from the actin filament; (b), that the crossbridge remains fixed to the actin filament after AMPPNP addition; and (c) that the ability of AMPPNP to cause apparent lengthening of a muscle fiber is due to its ability to cause a conformational change in the myosin crossbridge that has an axial component of approximately 1.6 nm/half-sarcomere. The present study, done only on chemically-skinned rabbit psoas fibers, confirms that AMPPNP can cause muscle fibers to lengthen by 0.15% but only for a narrow set of experimental conditions. When experimental conditions are varied over a wider range, it becomes apparent that the extent of lengthening of a rigor muscle fiber upon AMPPNP addition depends almost entirely on the strain present in the rigor fiber before AMPPNP addition. Addition of AMPPNP to an unstrained rigor fiber (one supporting zero tension), induces zero length change while addition of AMPPNP to very highly strained rigor fibers induces length changes greater than 0.15%. The data thus do not support the hypotheses that the crossbridges remain fixed to the actin filament after AMPPNP addition and that the size of the apparent length change induced by AMPPNP is related to the size of the axial component of a conformational change. Instead, the data support the idea that the ability of AMPPNP to cause lengthening of a rigor muscle fiber is related to its ability to accelerate the rate at which strained crossbridges detach from actin and reattach in positions in lesser strain. The data do not rule out a conformational change upon AMPPNP binding, they simply make clear that any attempt to measure a force response conceivably due to a conformational change, would be more than obscured by the force changes due to crossbridges detaching and reattaching in positions of lesser strain.
人们普遍认为,对于脊椎动物的横纹肌和昆虫的飞行肌来说,当在僵直状态下向肌纤维中添加ATP类似物腺苷 - 5'-亚氨二磷酸(AMPPNP)时,会使肌纤维伸长0.15%。这一点已被解释(马斯顿·S·B、C·D·罗杰和R·T·特里吉尔。1976年。《分子生物学杂志》104:263 - 267)为表明:(a)在僵直状态下,横桥固定在肌动蛋白丝上,即几乎从不与肌动蛋白丝分离;(b)添加AMPPNP后,横桥仍固定在肌动蛋白丝上;(c)AMPPNP能够使肌纤维明显伸长,是由于它能够引起肌球蛋白横桥构象变化,该变化的轴向分量约为1.6纳米/半肌节。本研究仅对化学去膜的兔腰大肌纤维进行,证实了AMPPNP可使肌纤维伸长0.15%,但仅在一组狭窄的实验条件下如此。当实验条件在更广泛的范围内变化时,很明显,添加AMPPNP后僵直肌纤维的伸长程度几乎完全取决于添加AMPPNP之前僵直纤维中存在的应变。向无应变的僵直纤维(承受零张力的纤维)中添加AMPPNP,诱导零长度变化,而向高度应变的僵直纤维中添加AMPPNP则诱导大于0.15%的长度变化。因此,这些数据不支持添加AMPPNP后横桥仍固定在肌动蛋白丝上以及AMPPNP诱导的明显长度变化大小与构象变化的轴向分量大小相关的假设。相反,数据支持这样一种观点,即AMPPNP使僵直肌纤维伸长的能力与其加速应变横桥从肌动蛋白上脱离并在应变较小的位置重新附着的速率的能力有关。数据并不排除AMPPNP结合时发生构象变化,只是明确表明,任何试图测量可能由构象变化引起的力响应的尝试,都会被由于横桥在应变较小的位置脱离和重新附着而导致的力变化所掩盖。